You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《滬深兩市》滬綜深成指半日升0.9%至1.1% 新冠藥概念股抽高
內地昨日(1日)新增本土確診病例409宗,新增本土無症狀感染者2,346宗。人行今日(2日)開展180億元人民幣(下同)7天期逆回購操作,單日淨回籠2,620億元。人民幣兌美元中間價今下調116點,連續第四日下調。A股三大指數齊低開,其後倒升,滬綜及深成指半日升0.9%至1.1%。 上證綜指中午收報2,995點,升26點或0.9%;深証成指升118點或1.1%,報10,852點;創業板指升33點或1.4%,報2,370點。 中資金融股偏軟,工行(601398.SH)跌0.7%。建行(601939.SH)跌近1%。 康希諾(688185.SH)吸入用新冠疫苗於江蘇十三個城市開展部署,股價漲停報253.5元。其他新冠藥概念股亦抽高,中國醫藥(600056.SH)及翰宇藥業(300199.SZ)升停板,復星醫藥(600196.SH)亦升8.2%。 國家工信部等多部門印發《虛擬現實與行業應用融合發展行動計劃(2022-2026年)》,虛擬實境概念股造好,風語築(603466.SH)盤前已告漲停,愷英網絡(002517.SZ)亦升停板。 至於內房股萬科(000002.SZ)及保利發展(600048.SH)各升0.7%及2.7%。 車股比亞迪(002594.SZ)及寧德時代(300750.SZ)分別升1.8%及1.1%。贛鋒鋰業(002460.SZ)及天齊鋰業(002466.SZ)跌0.2%至1.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account